SPONSOR
Menarini is the first Pharmaceutical Group in Italy, the 17th in Europe and the 37th worldwide. Menarini is present in over 100 countries across Europe, Asia, Africa and Australia, with a turnover of over 3 billion euros in 2014 and a work force of almost 17,000 employees wordwide. The Company is present in the main therapeutic areas with cardiovascular, gastro-enterology, antibiotic and respiratory products, drugs used in urology, diabetology, and anti-infl ammatory/analgesic agents. Menarini works through its major Company departments: R&D, Ethical drugs, OTC, Diagnostic, Manufacturing, and Scientific. Information. Menarini has its headquarters in Florence (Italy), via dei Sette Santi.
Acarpia Farmaceutici Srl is a pharmaceutical company based in Milan, focused on the enhancement of established well-known products with the aim of generating new value for patients, physicians and Health Service through their repositioning and development.
Acarpia believes in scientific research to discover new potential future benefit in products that have already proved their value in the past.
Acarpia mission is to develop a synergic interaction between clinical research and pharmaceutical industry, to make available pharmaceutical products of high therapeutic value at low cost to the medical community.
Acarpia supports medical education by sponsoring both congresses promoted by scientific societies and medical e-learning training courses.
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovative medicines and vaccines. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 170 years, we have worked to make a difference for all who rely on us. We routinely post information that may be important to investors on our website at www.Pfizer.com. In addition, to learn more, please visit us on www.Pfizer.com and follow us on Twitter at @Pfizer and @Pfizer News, LinkedIn, YouTube and like us on Facebook at Facebook.com/Pfizer.
Amgen is (proud to be) among the world's leading biotechnology companies. Thanks to the Biology First approach, Amgen exploits in-depth knowledge of biological processes to identify innovative solutions to meet the therapeutic needs of patients with serious illnesses. Throughout its history, Amgen has also proved to be a solid reality and a trusted partner of the health system, providing a vast wealth of ideas, scientific skills and therapies with the aim of supporting the patient along the entire therapeutic path, (reducing the social and economic burden of the disease).
Assita Spa is an agency company operating in multi-mandate, specialized in Professional Civil Liability and reference of professional associations, registers, scientific communities operating throughout the national territory.
Foresight, innovation and specialization have always been the founding values of the company, which, thanks to the support of major insurance companies, has consolidated its mission: to ensure the protection of the professional reputation and assets of the policyholders With four specialist divisions - Medical Division - Law Division - Technical Engineering - Business Consulting Division - dedicated to the various professional categories and a Legal Area dedicated to Claims, Assita S.p.A. has been the reference point for over 20,000 Italian professionals for 40 years the Assita team is made up of a structure of qualified professionals oriented exclusively to customer satisfaction.
On 31 July 2019 Assiteca S.p.A., the largest Italian Insurance Broker, acquired 80% of it, thus becoming the controlling shareholder.
The synergies with the Assiteca Group and the important development objectives of Assita S.p.A. allow the company to continue to be a leader in this particular market target Assita's objectives are multiple: preservation and consolidation of high specialization, enhancement of these skills from a digital perspective, expansion of collaborations aimed at the efficiency of the of policyholders, development of new agreements / conventions and dedicated products.
For the R.C. Professional and Legal Protection of Cardiologists, Assita has specifically cut out on this risk profile policies suitable and perfectly compliant with the Gelli Law 24/2017, for each professional regime Public Employee, Private Employee and Freelancer.
Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to help people and planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to drive sustainable development and generate a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2020, the Group employed around 100,000 people and had sales of 41.4 billion euros. R&D expenses before special items amounted to 4.9 billion euros.
Boehringer Ingelheim is working on breakthrough therapies that improve the lives of humans and animals. As a leading research-driven biopharmaceutical company, the company creates value through innovation in areas of high unmet medical need. Founded in 1885 and family-owned ever since, Boehringer Ingelheim takes a long-term perspective. Around 52,000 employees serve more than 130 markets in the three business areas, Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing.
Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices with approximately 125 countries with commercial representation, 36.000 employees at 141 sites including 16 principal manufacturing facilities worldwide. For more than 40 years, Boston Scientific has advanced the practice of less-invasive medicine by providing a broad and deep portfolio of innovative products, technologies and services across a wide range of medical specialties: 13.000+ products that change lives, investing nearly $1 billion annually in R&D, ranked 16th greenest company in the U.S. by Newsweek, committed to innovation with approximately 100 new products launched annually and 21.000+ patents issued globally.
The Company's products help physicians and other medical professionals improve their patients' quality of life by providing alternatives to surgery.
Boston Scientific is dedicated to transforming lives through innovative medical solutions that improve the health of patients around the world.
Daiichi Sankyo is dedicated to creating new modalities and innovative medicines by leveraging our world-class science and technology for our purpose “to contribute to the enrichment of quality of life around the world.” In addition to our current portfolio of medicines for cancer and cardiovascular disease, Daiichi Sankyo is primarily focused on developing novel therapies for people with cancer as well as other diseases with high unmet medical needs. With more than 100 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 16,000 employees around the world draw upon a rich legacy of innovation to realize our 2030 Vision to become an “Innovative Global Healthcare Company Contributing to the Sustainable Development of Society.”
FIAB is an Italian manufacturer of temporary cardiac pacing devices as diagnostic and pacing lead, trans-esophageal cardiac pacing leads and stimulators, external pacemaker, PSA and accessories for cardiac stimulation: moreover FIAB produces the “Esotest Multi “, a patented device for the esophageal temperature monitoring during FA ablation procedures.
G.Medical has been operating in the regional healthcare sector since 1998.
Our business partner is GE Healthcare Medical Systems, of which we are exclusive Reseller Agents for Sicily with the Ultrasound lines: Vivid for Cardiology, Voluson for Obstetrics and Gynecology, Logiq for Radiology, Venue for Point of Care.
Twenty years of experience gained in the public and private sector of health facilities located throughout Sicily, has allowed our company to characterize itself as a reference and reliable business of absolute value.
We are proud to be able to offer high quality standards of products and pre / post sales and technical assistance services, thanks to a flexible, dynamic and efficient organization.
Our goal is to guarantee all our customers the best combination of quality level and economic profile.
GI.PI. Medical is a growing, dynamic company specializing in the supply of medical devices for interventional cardiology.
Our partners are leading companies in the manufacture of advanced medical equipment.
We offer our customers the highest standards of quality that hospitals and private clinics can expect.
In addition, the company is organized in divisions enabling us to provide the most professional technical assistance wherever it is needed in our territory.
Halsa is the undisputed leader in the supply of biomedical devices and equipment with medium and high technological content in the territory of the Sicily Region.
For over 28 years, the company has been the partner selected by the main public and private hospitals and specialist medical practices throughout the region.
Halsa was founded in 1993 on the initiative of Giuseppe Antonino Cucè, the current Sole Director, who boasts over forty years of experience in the biomedical sector.
The company employs a team of professionals to provide innovative solutions and meet the needs of its customers.
The Halsa sales office is also equipped with a laboratory for technical assistance and electrical and functional safety checks and clinical engineering.
Our formula, closely linked to quality, service and efficiency are cornerstones of our corporate mission.
HALSA SRL: registered office in Via Pizzo Ferro n. 8 / A - Pedara (CT), VAT number 03014960870, Tel. 095/7513200 - 7511500, Fax 095/7511333
IBSA Farmaceutici, founded in 1992, is part of the Group Institut Biochimique SA and has its headquarter in Lodi, where the first plant was born. Over the years, IBSA has grown rapidly, expanding its offices in Rome and its production plant in Cassina de’ Pecchi (Milan), and becoming a leading economic and scientific player in the Italian pharmaceutical sector. Currently, IBSA employs 596 people and holds 82 patents families on cutting-edge pharmaceutical technologies. Technology, scientific know-how and R&D investments have allowed the Company to build an extensive product portfolio covering 10 therapeutic areas over the time. Drugs, medical devices and food supplements are developed and produced in Italy from our people and sold in more than 80 coutries worldwide. IBSA has based its philosophy on 4 pillars: Person, Innovation, Quality and Responsibility.
Medico S.p.A is an Italian manufacturing Company devoted to Cardiac Rhythm Management.
Thanks to an established tradition of commitment, passion and technological evolution, Medico spa continues to be at the forefront of progress in cardiac pacing.
Pacing devices and Cardiac resynchronization systems have been designed and developed to ensure top medical technology, allowing the physicians to suit the pacing therapy to the needs of every single patient.
Our exclusive TVI and i-ECG signals can be considered as an eye inside the heart: cardiac mechanic and electric function are both constantly controlled to provide hemodynamic monitoring in the long term.
At Medtronic, we believe in the power of medical technology to improve lives. Seven decades ago, our co-founder invented the battery-powered pacemaker. Today, we are among the largest medical device companies in the world. With operations in 150 countries, our products treat 70 health conditions and include cardiac devices, cranial and spine robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Our therapies help 72 million people a year and support our Mission to alleviate pain, restore health, and extend life.
Our people make it possible. We value diverse perspectives and encourage our 90,000+ employees to be themselves. We hold each other accountable, act with integrity, and make quality our highest priority.
We are privileged to be part of the communities where we live and work. We are committed to giving back and reducing our impact on the environment.
Let's take healthcare Further, Together.
MicroPort® is a global medical devices company, founded on the belief that every person has the right to high quality medical treatments and to live longer and healthier lives. All our solutions are designed to deliver on that belief. Our close collaboration with doctors and medical societies helps us accelerate innovation and develop solutions to transform medical treatment.
Today, MicroPort® operates in multiple international markets across multiple fields, including orthopedics, cardiovascular intervention, cardiac rhythm management, electro-physiology, endovascular, peripheral vascular intervention, among others.
MicroPort® CRM is a pioneering company in the physiological management of heart disease using high-tech implantable devices and diagnostic solutions. With dedicated R&D teams and state-of the-art manufacturing facilities, MicroPort® CRM designs, develops, and markets solutions for the management of heart rhythm disorders, such as implantable pacemakers and defibrillators, as well as for heart failure, with cardiac resynchronization therapy (CRT), worldwide
SEDA S.p.A. was founded in 1973 with the aim to search and select worldwide disposables, equipments and the most advanced devices.
SEDA has a long experience in Cardiology from 1973 with the mission to introduce in the Italian market the most innovative technology in order to improve the patient treatment.
Vifor Pharma is a world leader in the discovery, development, manufacture and marketing of pharmaceutical products for the treatment of iron deficiency. The company also offers a diversified portfolio of other medicines. Vifor Pharma's goal is to be a global leader in iron deficiency, nephrology and cardio-renal therapies and is committed to helping patients around the world with severe and chronic diseases to lead better and healthier lives.
